Literature DB >> 19828416

Plasmacytoid lymphoma treated with rituximab as first-line monotherapy.

Isabel Blancas, Irene Zarcos, Francisco J Gómez, María Teresa Delgado, Josefa Carrillo, Marta Legerén, Belén Ríos, Eduardo Pacios, José Miguel Jurado, María José Sánchez, Rocío Fonseca, José Luis García Puche.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19828416     DOI： 10.1007/s12094-009-0429-4

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  11 in total

1.  Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.

Authors:  J M Foran; A Z Rohatiner; B Coiffier; T Barbui; S A Johnson; W Hiddemann; J A Radford; A J Norton; S M Tollerfield; M P Wilson; T A Lister
Journal:  J Clin Oncol       Date:  1999-02       Impact factor: 44.544

Review 2.  Diagnosis and management of Waldenstrom's macroglobulinemia.

Authors:  Meletios A Dimopoulos; Robert A Kyle; Athanasios Anagnostopoulos; Steven P Treon
Journal:  J Clin Oncol       Date:  2005-03-01       Impact factor: 44.544

3.  B-cell neoplasms of the lymphocytic, lymphoplasmacytoid, and plasma cell types: immunohistologic analysis and clinical correlation.

Authors:  N L Harris; A K Bhan
Journal:  Hum Pathol       Date:  1985-08       Impact factor: 3.466

4.  Updated Kiel classification for lymphomas.

Authors:  A G Stansfeld; J Diebold; H Noel; Y Kapanci; F Rilke; G Kelényi; C Sundstrom; K Lennert; J A van Unnik; O Mioduszewska
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

5.  Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: a phase II trial in the North Central Cancer Treatment Group.

Authors:  Thomas E Witzig; Allen M Vukov; Thomas M Habermann; Susan Geyer; Paul J Kurtin; William R Friedenberg; William L White; Haji I Chalchal; Patrick J Flynn; Thomas R Fitch; Debra A Welker
Journal:  J Clin Oncol       Date:  2005-01-18       Impact factor: 44.544

6.  Treatment of Waldenström's macroglobulinemia with rituximab.

Authors:  Meletios A Dimopoulos; Constantinos Zervas; Athanassios Zomas; Christos Kiamouris; Nora A Viniou; Vassiliki Grigoraki; Christos Karkantaris; Chrisanthi Mitsouli; Dimitra Gika; John Christakis; Nikolaos Anagnostopoulos
Journal:  J Clin Oncol       Date:  2002-05-01       Impact factor: 44.544

7.  Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network.

Authors:  John D Hainsworth; Sharlene Litchy; Lisa H Morrissey; Michael B Andrews; Manuel Grimaldi; Matthew McCarty; F Anthony Greco
Journal:  J Clin Oncol       Date:  2005-01-04       Impact factor: 44.544

8.  Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct clinical features and outcome.

Authors:  F Berger; P Felman; A Sonet; G Salles; Y Bastion; P A Bryon; B Coiffier
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

9.  Treatment of indolent B-Cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi.

Authors:  Luca Baldini; Maura Brugiatelli; Stefano Luminari; Marco Lombardo; Francesco Merli; Stefano Sacchi; Paolo Gobbi; Marina Liberati; Luigi Cavanna; Mariangela Colombi; Caterina Stelitano; Maria Goldaniga; Fortunato Morabito; Massimo Federico; Vittorio Silingardi
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.